TCT-173 The ABSORB III and ABSORB Japan Trials: Final Intravascular Ultrasound Results
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2019.08.229
Abstract: The pivotal ABSORB III and Japan trials randomized patients with noncomplex coronary artery disease to Absorb bioresorbable vascular scaffolds (BVS) versus cobalt-chromium Xience everolimus-eluting stents (EES) (both Abbott Vascular, Santa Clara, California). Formal intravascular ultrasound… read more here.
Keywords: absorb iii; japan trials; tct 173; intravascular ultrasound ... See more keywords
Early improvement as a predictor of later response to lurasidone in schizophrenia from Japan trials: A diagnostic test
Sign Up to like & getrecommendations! Published in 2022 at "Psychiatry and Clinical Neurosciences"
DOI: 10.1111/pcn.13377
Abstract: A recent 6-week, double-blind, randomized, placebo-controlled trial on lurasidone for acute schizophrenia in Japan 1 demonstrated that lurasidone (LUR) 40 mg/day (LUR40) improved Positive and Negative Syndrome Scale (PANSS) 2 total score (PANSS-T) while being… read more here.
Keywords: japan trials; schizophrenia; lurasidone; panss ... See more keywords